F. E. Bader
Impact in
- Pharmacology top 5%
- Alkaloids: synthesis and pharmacology
- Microbial Natural Products and Biosynthesis
- Plant-based Medicinal Research
- Organic Chemistry top 5%
- Chemical synthesis and alkaloids
- Asymmetric Synthesis and Catalysis
- Synthetic Organic Chemistry Methods
Papers in
-
- Asymmetric Synthesis and Catalysis 3
- Chemical synthesis and alkaloids 3
-
- Plant-based Medicinal Research 3
- Alkaloids: synthesis and pharmacology 3
- Co-authors
- R. W. Kierstead (3 shared papers)H. Bickel (3 shared papers)R. B. Woodward (3 shared papers)A. Frey (1 shared paper)E. Schlittler (6 shared papers)Helmut Schwarz (3 shared papers)Katia Boven (2 shared papers)Nicole Casadevall (2 shared papers)
- Journals
- Helvetica Chimica Acta (7 papers)Journal of the American Chemical Society (4 papers)Nephrology Dialysis Transplantation (2 papers)Cellular and Molecular Life Sciences (1 paper)Tetrahedron (1 paper)
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
F. E. Bader
17 papers receiving 543 citations
Peers
Comparison fields: 5 of 84
- Pharmacology 133
- Organic Chemistry 361
- Biochemistry 49
- Biotechnology 36
- Pharmacology 70
Countries citing papers authored by F. E. Bader
This map shows the geographic impact of F. E. Bader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. E. Bader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. E. Bader more than expected).
Fields of papers citing papers by F. E. Bader
This network shows the impact of papers produced by F. E. Bader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. E. Bader. The network helps show where F. E. Bader may publish in the future.
Co-authors
The 23 scholars most cited alongside F. E. Bader, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1958 | 207 | |
| 2 | 1956 | 119 | |
| 3 | 2005 | 66 | |
| 4 | 1956 | 55 | |
| 5 | 1959 | 26 | |
| 6 | 1953 | 20 | |
| 7 | 1954 | 18 | |
| 8 | 1952 | 17 | |
| 9 | 1952 | 14 | |
| 10 | 1953 | 11 | |
| 11 | 1954 | 9 | |
| 12 | 1955 | 8 | |
| 13 | 1974 | 7 | |
| 14 | 1971 | 7 | |
| 15 | 1954 | 7 | |
| 16 | 2006 | 5 | |
| 17 | 1951 | 5 |
About F. E. Bader
F. E. Bader is a scholar working on Organic Chemistry, Pharmacology, Oncology, Pharmacology and Biomaterials, having authored 17 papers that have together received 601 indexed citations. Recurring topics across this work include Asymmetric Synthesis and Catalysis (3 papers), Plant-based Medicinal Research (3 papers), Alkaloids: synthesis and pharmacology (3 papers), Chemical synthesis and alkaloids (3 papers), Cancer Treatment and Pharmacology (2 papers), Biosimilars and Bioanalytical Methods (2 papers), Erythropoietin and Anemia Treatment (2 papers) and Phytochemistry and Bioactive Compounds (2 papers). The work is most often cited by research in Pharmacology (133 citations), Organic Chemistry (361 citations), Biochemistry (49 citations), Biotechnology (36 citations) and Pharmacology (70 citations). F. E. Bader has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include R. W. Kierstead, H. Bickel, R. B. Woodward, A. Frey, E. Schlittler, Helmut Schwarz, Katia Boven, Nicole Casadevall, Jérôme Rossert and Kai‐Uwe Eckardt. Their work appears in journals such as Helvetica Chimica Acta, Journal of the American Chemical Society, Nephrology Dialysis Transplantation, Cellular and Molecular Life Sciences and Tetrahedron.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.